Diagnostic value of FibroTest with normal serum aminotransferases [3]

Hepatology

Volumn 43, Issue 2, 2006, Pages 374-375

  Poynard, Thierry ^a   Munteanu, Mona ^b   Ngo, Yen ^a   Torres, Mercedes ^a   Benhamou, Yves ^a   Thabut, Dominique ^a   Ratziu, Vlad ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Biopredictive   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; BIOLOGICAL MARKER;

AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; HEPATITIS B; HEPATITIS C; HUMAN; LETTER; LIVER BIOPSY; LIVER FIBROSIS; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TECHNIQUE;

ALANINE TRANSAMINASE; ALGORITHMS; BIOPSY; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; SENSITIVITY AND SPECIFICITY;

EID: 33644501851     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21086     Document Type: Letter

References (7)

1. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, Pirisi M. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. HEPATOLOGY 2005;42:838-845.
2. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075.
3. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004;50:1344-1355.
4. Castéra L, Vergniol J, Foucher J, Brigitte Le Bail B, Chanteloup E, et al. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50.
5. Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Portal I, Renou Cet al. Independent prospective multicenter validation of biochemical markers (FibroTest-ActiTest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis Am J Gastroenterol 2005; in press.
6. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. HEPATOLOGY 2003;38:481-492.
7. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. HEPATOLOGY 1998;27:1213-1219.